We are excited to announce the release of Walden Group’s 2024 Corporate Social Responsibility (CSR) Report. This comprehensive document underscores our unwavering commitment to sustainability, social responsibility, and governance.
Eurotranspharma, as part of the Walden Group, has been actively involved in various CSR actions. Our dedication to minimizing our carbon emissions is evident in our roadmap to achieving net zero by 2040. We continuously measure and evaluate our greenhouse gas (GHG) emissions following globally acknowledged carbon accounting standards, such as ISO 14083, as specified by the GHG Protocol.
The report also highlights our sustainable actions, including optimizing transport plans, investing in alternative fuels, and empowering our teams with ecological driving training and technology. These initiatives are part of our broader strategy to reduce our environmental impact and contribute to a greener future.
We invite you to read the full report to learn more about our journey and future goals. We also invite you to learn more about our sustainability goals on our webpage dedicated to the subject.
